Companies:
11,396
total market cap:
$145.355 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Mativ Holdings
MATV
#7138
Rank
$0.61 B
Marketcap
๐บ๐ธ
United States
Country
$11.13
Share price
-0.18%
Change (1 day)
-8.17%
Change (1 year)
๐ฆ Packaging
๐ Pulp and paper
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Dividends
Dividend yield
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Mativ Holdings
Quarterly Reports (10-Q)
Financial Year FY2026 Q3
Mativ Holdings - 10-Q quarterly report FY2026 Q3
Text size:
Small
Medium
Large
0001000623
12/31
2026
Q3
FALSE
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
matv:segment
xbrli:pure
iso4217:EUR
0001000623
2026-01-01
2026-09-30
0001000623
2026-11-02
0001000623
2026-07-01
2026-09-30
0001000623
2025-07-01
2025-09-30
0001000623
2025-01-01
2025-09-30
0001000623
2026-09-30
0001000623
2025-12-31
0001000623
us-gaap:CommonStockMember
2025-06-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2025-06-30
0001000623
us-gaap:RetainedEarningsMember
2025-06-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-06-30
0001000623
2025-06-30
0001000623
us-gaap:RetainedEarningsMember
2025-07-01
2025-09-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-07-01
2025-09-30
0001000623
us-gaap:CommonStockMember
2025-07-01
2025-09-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2025-07-01
2025-09-30
0001000623
us-gaap:CommonStockMember
2025-09-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2025-09-30
0001000623
us-gaap:RetainedEarningsMember
2025-09-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-09-30
0001000623
2025-09-30
0001000623
us-gaap:CommonStockMember
2026-06-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2026-06-30
0001000623
us-gaap:RetainedEarningsMember
2026-06-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-06-30
0001000623
2026-06-30
0001000623
us-gaap:RetainedEarningsMember
2026-07-01
2026-09-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-07-01
2026-09-30
0001000623
us-gaap:CommonStockMember
2026-07-01
2026-09-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2026-07-01
2026-09-30
0001000623
us-gaap:CommonStockMember
2026-09-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2026-09-30
0001000623
us-gaap:RetainedEarningsMember
2026-09-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-09-30
0001000623
us-gaap:CommonStockMember
2024-12-31
0001000623
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0001000623
us-gaap:RetainedEarningsMember
2024-12-31
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0001000623
2024-12-31
0001000623
us-gaap:RetainedEarningsMember
2025-01-01
2025-09-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-09-30
0001000623
us-gaap:CommonStockMember
2025-01-01
2025-09-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-09-30
0001000623
us-gaap:CommonStockMember
2025-12-31
0001000623
us-gaap:AdditionalPaidInCapitalMember
2025-12-31
0001000623
us-gaap:RetainedEarningsMember
2025-12-31
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-12-31
0001000623
us-gaap:RetainedEarningsMember
2026-01-01
2026-09-30
0001000623
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2026-01-01
2026-09-30
0001000623
us-gaap:CommonStockMember
2026-01-01
2026-09-30
0001000623
us-gaap:AdditionalPaidInCapitalMember
2026-01-01
2026-09-30
0001000623
us-gaap:NonrecourseMember
us-gaap:AssetPledgedAsCollateralWithoutRightMember
2026-09-30
0001000623
us-gaap:NonrecourseMember
us-gaap:AssetPledgedAsCollateralWithoutRightMember
2025-12-31
0001000623
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2026-09-30
0001000623
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2025-12-31
0001000623
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2026-09-30
0001000623
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2025-12-31
0001000623
us-gaap:AccumulatedTranslationAdjustmentMember
2026-09-30
0001000623
us-gaap:AccumulatedTranslationAdjustmentMember
2025-12-31
0001000623
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2026-07-01
2026-09-30
0001000623
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2025-07-01
2025-09-30
0001000623
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2026-07-01
2026-09-30
0001000623
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2025-07-01
2025-09-30
0001000623
us-gaap:AccumulatedTranslationAdjustmentMember
2026-07-01
2026-09-30
0001000623
us-gaap:AccumulatedTranslationAdjustmentMember
2025-07-01
2025-09-30
0001000623
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2026-01-01
2026-09-30
0001000623
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2025-01-01
2025-09-30
0001000623
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2026-01-01
2026-09-30
0001000623
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2025-01-01
2025-09-30
0001000623
us-gaap:AccumulatedTranslationAdjustmentMember
2026-01-01
2026-09-30
0001000623
us-gaap:AccumulatedTranslationAdjustmentMember
2025-01-01
2025-09-30
0001000623
us-gaap:CustomerRelationshipsMember
2026-09-30
0001000623
us-gaap:DevelopedTechnologyRightsMember
2026-09-30
0001000623
us-gaap:TradeNamesMember
2026-09-30
0001000623
us-gaap:PatentsMember
2026-09-30
0001000623
us-gaap:CustomerRelationshipsMember
2025-12-31
0001000623
us-gaap:DevelopedTechnologyRightsMember
2025-12-31
0001000623
us-gaap:TradeNamesMember
2025-12-31
0001000623
us-gaap:PatentsMember
2025-12-31
0001000623
matv:FAMSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OperatingSegmentsMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OperatingSegmentsMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OperatingSegmentsMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
us-gaap:OperatingSegmentsMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
us-gaap:EmployeeSeveranceMember
us-gaap:OperatingSegmentsMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
us-gaap:OtherRestructuringMember
us-gaap:OperatingSegmentsMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
us-gaap:OperatingSegmentsMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
us-gaap:OperatingSegmentsMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
us-gaap:OperatingSegmentsMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
us-gaap:OperatingSegmentsMember
2025-01-01
2025-09-30
0001000623
us-gaap:EmployeeSeveranceMember
us-gaap:MaterialReconcilingItemsMember
2026-07-01
2026-09-30
0001000623
us-gaap:EmployeeSeveranceMember
us-gaap:MaterialReconcilingItemsMember
2025-07-01
2025-09-30
0001000623
us-gaap:EmployeeSeveranceMember
us-gaap:MaterialReconcilingItemsMember
2026-01-01
2026-09-30
0001000623
us-gaap:EmployeeSeveranceMember
us-gaap:MaterialReconcilingItemsMember
2025-01-01
2025-09-30
0001000623
us-gaap:MaterialReconcilingItemsMember
2026-07-01
2026-09-30
0001000623
us-gaap:MaterialReconcilingItemsMember
2025-07-01
2025-09-30
0001000623
us-gaap:MaterialReconcilingItemsMember
2026-01-01
2026-09-30
0001000623
us-gaap:MaterialReconcilingItemsMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
us-gaap:FacilityClosingMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
us-gaap:FacilityClosingMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
us-gaap:FacilityClosingMember
2026-09-30
0001000623
us-gaap:OtherAssetsCurrent
2026-09-30
0001000623
us-gaap:OtherAssetsCurrent
2025-12-31
0001000623
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
matv:NewCreditFacilityRevolvingCreditAgreementMember
2026-09-30
0001000623
us-gaap:RevolvingCreditFacilityMember
us-gaap:LineOfCreditMember
matv:NewCreditFacilityRevolvingCreditAgreementMember
2025-12-31
0001000623
us-gaap:SecuredDebtMember
us-gaap:LineOfCreditMember
matv:TermLoanFacilityAMember
2026-09-30
0001000623
us-gaap:SecuredDebtMember
us-gaap:LineOfCreditMember
matv:TermLoanFacilityAMember
2025-12-31
0001000623
us-gaap:SecuredDebtMember
us-gaap:LineOfCreditMember
matv:TermLoanFacilityBMember
2026-09-30
0001000623
us-gaap:SecuredDebtMember
us-gaap:LineOfCreditMember
matv:TermLoanFacilityBMember
2025-12-31
0001000623
us-gaap:SecuredDebtMember
us-gaap:LineOfCreditMember
matv:DelayedDrawTermLoanFacilityMember
2026-09-30
0001000623
us-gaap:SecuredDebtMember
us-gaap:LineOfCreditMember
matv:DelayedDrawTermLoanFacilityMember
2025-12-31
0001000623
us-gaap:UnsecuredDebtMember
matv:A8.000SeniorUnsecuredNotesDue2029Member
2026-09-30
0001000623
us-gaap:UnsecuredDebtMember
matv:A8.000SeniorUnsecuredNotesDue2029Member
2025-12-31
0001000623
us-gaap:MediumTermNotesMember
matv:GermanLoanAgreementMember
2026-09-30
0001000623
us-gaap:MediumTermNotesMember
matv:GermanLoanAgreementMember
2025-12-31
0001000623
matv:A8.000SeniorUnsecuredNotesDue2029Member
2024-10-07
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:NewCreditFacilityMember
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityAMember
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityBMember
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
2026-04-03
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityAMember
2026-04-03
2026-04-03
0001000623
us-gaap:UnsecuredDebtMember
matv:A8.000SeniorUnsecuredNotesDue2029Member
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityBMember
2026-04-03
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityAMember
srt:MinimumMember
2026-04-03
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityAMember
srt:MaximumMember
2026-04-03
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityBMember
srt:MinimumMember
2026-04-03
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TermLoanFacilityBMember
srt:MaximumMember
2026-04-03
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TriggeringEventTwoMember
matv:NewCreditFacilityMember
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:NewCreditFacilityMember
2026-04-03
2026-04-03
0001000623
us-gaap:LineOfCreditMember
us-gaap:RevolvingCreditFacilityMember
matv:TriggeringEventTwoMember
matv:NewCreditFacilityMember
2026-04-03
2026-04-03
0001000623
us-gaap:RevolvingCreditFacilityMember
matv:PreviousSeniorCreditFacilityMember
2026-09-30
0001000623
us-gaap:SecuredDebtMember
matv:TermLoanFacilityAMember
2026-09-30
0001000623
us-gaap:SecuredDebtMember
matv:TermLoanFacilityBMember
2026-09-30
0001000623
us-gaap:UnsecuredDebtMember
2026-09-30
0001000623
us-gaap:UnsecuredDebtMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CrossCurrencyInterestRateContractMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CrossCurrencyInterestRateContractMember
2025-12-31
0001000623
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2026-09-30
0001000623
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccountsReceivableNetCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccountsPayableCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherAssetsNoncurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherLiabilitiesNoncurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccountsReceivableNetCurrent
us-gaap:InterestRateContractMember
us-gaap:CashFlowHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccruedLiabilitiesCurrent
us-gaap:InterestRateContractMember
us-gaap:CashFlowHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherAssetsNoncurrent
us-gaap:InterestRateContractMember
us-gaap:CashFlowHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherLiabilitiesNoncurrent
us-gaap:InterestRateContractMember
us-gaap:CashFlowHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:NondesignatedMember
us-gaap:AccountsReceivableNetCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:NondesignatedMember
us-gaap:AccruedLiabilitiesCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:NondesignatedMember
us-gaap:FairValueHedgingMember
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccountsReceivableNetCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:AccruedLiabilitiesCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherAssetsNoncurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherLiabilitiesNoncurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherAssetsNoncurrent
us-gaap:InterestRateContractMember
us-gaap:CashFlowHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:OtherLiabilitiesNoncurrent
us-gaap:InterestRateContractMember
us-gaap:CashFlowHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:NondesignatedMember
us-gaap:AccountsReceivableNetCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:NondesignatedMember
us-gaap:AccruedLiabilitiesCurrent
us-gaap:ForeignExchangeContractMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:NondesignatedMember
us-gaap:FairValueHedgingMember
2025-12-31
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CashFlowHedgingMember
2026-07-01
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CashFlowHedgingMember
2025-07-01
2025-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CashFlowHedgingMember
2026-01-01
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:CashFlowHedgingMember
2025-01-01
2025-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:NetInvestmentHedgingMember
2026-07-01
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:NetInvestmentHedgingMember
2025-07-01
2025-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:NetInvestmentHedgingMember
2026-01-01
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
us-gaap:NetInvestmentHedgingMember
2025-01-01
2025-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
2026-07-01
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
2025-07-01
2025-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
2026-01-01
2026-09-30
0001000623
us-gaap:DesignatedAsHedgingInstrumentMember
2025-01-01
2025-09-30
0001000623
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
2026-07-01
2026-09-30
0001000623
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
2025-07-01
2025-09-30
0001000623
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
2026-01-01
2026-09-30
0001000623
us-gaap:NondesignatedMember
us-gaap:ForeignExchangeContractMember
2025-01-01
2025-09-30
0001000623
us-gaap:InterestRateSwapMember
2026-01-01
2026-09-30
0001000623
srt:MaximumMember
2023-11-30
0001000623
us-gaap:NaturalDisastersAndOtherCasualtyEventsMember
2026-07-27
2026-07-27
0001000623
us-gaap:InventoriesMember
us-gaap:NaturalDisastersAndOtherCasualtyEventsMember
2026-01-01
2026-09-30
0001000623
us-gaap:InventoriesMember
us-gaap:NaturalDisastersAndOtherCasualtyEventsMember
2026-07-01
2026-09-30
0001000623
us-gaap:PropertyPlantAndEquipmentMember
us-gaap:NaturalDisastersAndOtherCasualtyEventsMember
2026-01-01
2026-09-30
0001000623
us-gaap:PropertyPlantAndEquipmentMember
us-gaap:NaturalDisastersAndOtherCasualtyEventsMember
2026-07-01
2026-09-30
0001000623
us-gaap:NaturalDisastersAndOtherCasualtyEventsMember
2026-01-01
2026-09-30
0001000623
us-gaap:NaturalDisastersAndOtherCasualtyEventsMember
2026-07-01
2026-09-30
0001000623
us-gaap:UnionizedEmployeesConcentrationRiskMember
us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember
country:US
2026-01-01
2026-09-30
0001000623
us-gaap:UnionizedEmployeesConcentrationRiskMember
us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsMember
us-gaap:NonUsMember
2026-01-01
2026-09-30
0001000623
us-gaap:UnionizedEmployeesConcentrationRiskMember
us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsExpiringWithinOneYearMember
country:US
2026-01-01
2026-09-30
0001000623
us-gaap:UnionizedEmployeesConcentrationRiskMember
us-gaap:WorkforceSubjectToCollectiveBargainingArrangementsExpiringWithinOneYearMember
us-gaap:NonUsMember
2026-01-01
2026-09-30
0001000623
country:US
us-gaap:PensionPlansDefinedBenefitMember
2026-07-01
2026-09-30
0001000623
country:US
us-gaap:PensionPlansDefinedBenefitMember
2025-07-01
2025-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:PensionPlansDefinedBenefitMember
2026-07-01
2026-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:PensionPlansDefinedBenefitMember
2025-07-01
2025-09-30
0001000623
country:US
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2026-07-01
2026-09-30
0001000623
country:US
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2025-07-01
2025-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2026-07-01
2026-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2025-07-01
2025-09-30
0001000623
country:US
us-gaap:PensionPlansDefinedBenefitMember
2026-01-01
2026-09-30
0001000623
country:US
us-gaap:PensionPlansDefinedBenefitMember
2025-01-01
2025-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:PensionPlansDefinedBenefitMember
2026-01-01
2026-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:PensionPlansDefinedBenefitMember
2025-01-01
2025-09-30
0001000623
country:US
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2026-01-01
2026-09-30
0001000623
country:US
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2025-01-01
2025-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2026-01-01
2026-09-30
0001000623
us-gaap:ForeignPlanMember
us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
country:US
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
country:US
2026-07-01
2026-09-30
0001000623
country:US
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
country:US
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
country:US
2025-07-01
2025-09-30
0001000623
country:US
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
srt:EuropeMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
srt:EuropeMember
2026-07-01
2026-09-30
0001000623
srt:EuropeMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
srt:EuropeMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
srt:EuropeMember
2025-07-01
2025-09-30
0001000623
srt:EuropeMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
srt:AsiaPacificMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
srt:AsiaPacificMember
2026-07-01
2026-09-30
0001000623
srt:AsiaPacificMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
srt:AsiaPacificMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
srt:AsiaPacificMember
2025-07-01
2025-09-30
0001000623
srt:AsiaPacificMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
matv:AmericasExcludingUnitedStatesMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
matv:AmericasExcludingUnitedStatesMember
2026-07-01
2026-09-30
0001000623
matv:AmericasExcludingUnitedStatesMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
matv:AmericasExcludingUnitedStatesMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
matv:AmericasExcludingUnitedStatesMember
2025-07-01
2025-09-30
0001000623
matv:AmericasExcludingUnitedStatesMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
matv:OtherForeignCountriesMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
matv:OtherForeignCountriesMember
2026-07-01
2026-09-30
0001000623
matv:OtherForeignCountriesMember
2026-07-01
2026-09-30
0001000623
matv:FAMSegmentMember
matv:OtherForeignCountriesMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
matv:OtherForeignCountriesMember
2025-07-01
2025-09-30
0001000623
matv:OtherForeignCountriesMember
2025-07-01
2025-09-30
0001000623
matv:SASSegmentMember
2026-07-01
2026-09-30
0001000623
matv:SASSegmentMember
2025-07-01
2025-09-30
0001000623
matv:FAMSegmentMember
country:US
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
country:US
2026-01-01
2026-09-30
0001000623
country:US
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
country:US
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
country:US
2025-01-01
2025-09-30
0001000623
country:US
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
srt:EuropeMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
srt:EuropeMember
2026-01-01
2026-09-30
0001000623
srt:EuropeMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
srt:EuropeMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
srt:EuropeMember
2025-01-01
2025-09-30
0001000623
srt:EuropeMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
srt:AsiaPacificMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
srt:AsiaPacificMember
2026-01-01
2026-09-30
0001000623
srt:AsiaPacificMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
srt:AsiaPacificMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
srt:AsiaPacificMember
2025-01-01
2025-09-30
0001000623
srt:AsiaPacificMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
matv:AmericasExcludingUnitedStatesMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
matv:AmericasExcludingUnitedStatesMember
2026-01-01
2026-09-30
0001000623
matv:AmericasExcludingUnitedStatesMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
matv:AmericasExcludingUnitedStatesMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
matv:AmericasExcludingUnitedStatesMember
2025-01-01
2025-09-30
0001000623
matv:AmericasExcludingUnitedStatesMember
2025-01-01
2025-09-30
0001000623
matv:FAMSegmentMember
matv:OtherForeignCountriesMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
matv:OtherForeignCountriesMember
2026-01-01
2026-09-30
0001000623
matv:OtherForeignCountriesMember
2026-01-01
2026-09-30
0001000623
matv:FAMSegmentMember
matv:OtherForeignCountriesMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
matv:OtherForeignCountriesMember
2025-01-01
2025-09-30
0001000623
matv:OtherForeignCountriesMember
2025-01-01
2025-09-30
0001000623
matv:SASSegmentMember
2026-01-01
2026-09-30
0001000623
matv:SASSegmentMember
2025-01-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:FiltrationNettingMember
2026-07-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:FiltrationNettingMember
2025-07-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:FiltrationNettingMember
2026-01-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:FiltrationNettingMember
2025-01-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:AdvancedFilmsMember
2026-07-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:AdvancedFilmsMember
2025-07-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:AdvancedFilmsMember
2026-01-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:AdvancedFilmsMember
2025-01-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:TapesLabelsLinersMember
2026-07-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:TapesLabelsLinersMember
2025-07-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:TapesLabelsLinersMember
2026-01-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:TapesLabelsLinersMember
2025-01-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:PaperPackagingMember
2026-07-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:PaperPackagingMember
2025-07-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:PaperPackagingMember
2026-01-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
matv:PaperPackagingMember
2025-01-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:HealthCareOtherMember
2026-07-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:HealthCareOtherMember
2025-07-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:HealthCareOtherMember
2026-01-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
us-gaap:HealthCareOtherMember
2025-01-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
2026-07-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
2025-07-01
2025-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
2026-01-01
2026-09-30
0001000623
us-gaap:ProductConcentrationRiskMember
us-gaap:RevenueFromContractWithCustomerSegmentBenchmarkMember
2025-01-01
2025-09-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
(Mark One)
☒
For the quarterly period ended
September 30, 2026
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
For the transition period from __________________to __________________
1-13948
(Commission file number)
MATIV HOLDINGS, INC.
(Exact name of registrant as specified in its charter)
Delaware
62-1612879
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
100 Kimball Pl,
Suite 600
Alpharetta,
Georgia
30009
(Address of principal executive offices)
(Zip Code)
1-
770
-
569-4229
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Common stock, $0.10 par value
MATV
New York Stock Exchange
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☐
Accelerated filer
☒
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes
☐
No
☒
The Company had
55,191,997
shares of common stock outstanding as of November 2, 2026.
MATIV HOLDINGS, INC.
TABLE OF CONTENTS
Page
Part I. - Financial Information
Item 1.
Financial Statements
2
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
26
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
34
Item 4.
Controls and Procedures
35
Part II. - Other Information
Item 1.
Legal Proceedings
36
Item 1A.
Risk Factors
36
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
36
Item 3.
Defaults Upon Senior Securities
36
Item 4.
Mine Safety Disclosures
36
Item 5.
Other Information
36
Item 6.
Exhibits
37
Signatures
38
1
PART I - FINANCIAL INFORMATION
Item 1.
Financial Statements
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
(in millions, except per share amounts)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Net sales
$
499.5
$
513.7
$
1,510.9
$
1,523.9
Cost of products sold
401.8
414.3
1,215.0
1,248.2
Gross profit
97.7
99.4
295.9
275.7
Selling and general expense
54.8
53.7
166.2
174.2
Research and development expense
4.8
5.6
15.2
18.6
Intangible asset amortization expense
15.5
16.0
47.3
47.3
Total nonmanufacturing expenses
75.1
75.3
228.7
240.1
Goodwill impairment expense
—
—
—
411.9
Restructuring and other impairment expense
2.7
8.1
4.7
18.2
Operating profit (loss)
19.9
16.0
62.5
(
394.5
)
Interest expense
18.1
17.7
54.9
54.1
Loss on debt extinguishment
—
—
8.7
—
Other income (expense), net
(
0.4
)
(
3.9
)
0.6
(
4.2
)
Income (loss) before income taxes
1.4
(
5.6
)
(
0.5
)
(
452.8
)
Income tax expense (benefit), net
2.6
(
2.4
)
8.8
(
14.6
)
Net loss
$
(
1.2
)
$
(
3.2
)
$
(
9.3
)
$
(
438.2
)
Net loss per share:
Basic
$
(
0.03
)
$
(
0.06
)
$
(
0.18
)
$
(
8.04
)
Diluted
$
(
0.03
)
$
(
0.06
)
$
(
0.18
)
$
(
8.04
)
Weighted average shares outstanding:
Basic
55,190,100
54,671,900
55,046,800
54,582,100
Diluted
55,190,100
54,671,900
55,046,800
54,582,100
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
2
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in millions)
(Unaudited)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Net loss
$
(
1.2
)
$
(
3.2
)
$
(
9.3
)
$
(
438.2
)
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments
1.6
(
0.7
)
(
8.8
)
10.4
Unrealized loss on derivative instruments
(
0.6
)
(
3.3
)
(
1.0
)
(
15.1
)
Net gain (loss) from postretirement benefit plans
0.2
(
8.3
)
0.7
(
8.2
)
Other comprehensive income (loss)
1.2
(
12.3
)
(
9.1
)
(
12.9
)
Comprehensive income (loss)
$
—
$
(
15.5
)
$
(
18.4
)
$
(
451.1
)
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
3
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(in millions, except per share amounts)
(Unaudited)
September 30,
2026
December 31, 2025
ASSETS
Cash and cash equivalents
$
97.3
$
84.2
Restricted cash
4.2
5.6
Accounts receivable, net
250.3
180.9
Inventories, net
329.1
329.1
Income taxes receivable
9.0
17.7
Other current assets
19.4
21.1
Total current assets
709.3
638.6
Property, plant and equipment, net
585.2
624.9
Operating lease right-of-use assets
57.3
48.4
Deferred income tax assets
97.3
104.0
Goodwill
56.2
57.6
Intangible assets, net
459.6
514.2
Other assets
65.6
63.9
Total assets
$
2,030.5
$
2,051.6
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current debt
$
3.8
$
2.9
Operating lease liabilities
8.8
9.0
Accounts payable
219.6
160.7
Income taxes payable
3.4
1.5
Accrued expenses and other current liabilities
131.8
111.2
Total current liabilities
367.4
285.3
Long-term debt
972.6
1,015.3
Finance lease liabilities, noncurrent
14.7
16.1
Operating lease liabilities, noncurrent
47.4
38.8
Pension and other postretirement benefits
49.1
53.8
Deferred income tax liabilities
69.3
74.9
Other liabilities
42.9
68.7
Total liabilities
1,563.4
1,552.9
Stockholders’ equity:
Preferred stock, $
0.10
par value;
10,000,000
shares authorized;
none
issued or outstanding
—
—
Common stock, $
0.10
par value;
100,000,000
shares authorized;
55,191,997
and
54,681,114
shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively
5.5
5.5
Additional paid-in-capital
688.7
685.0
Accumulated deficit
(
222.0
)
(
195.8
)
Accumulated other comprehensive income (loss), net of tax
(
5.1
)
4.0
Total stockholders’ equity
467.1
498.7
Total liabilities and stockholders’ equity
$
2,030.5
$
2,051.6
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
4
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in millions, except per share amounts)
(Unaudited)
Common Stock
Additional
Paid-In Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Shares
Amount
Total
Balance, June 30, 2025
54,648,991
$
5.5
$
680.7
$
(
282.1
)
$
12.5
$
416.6
Net loss
—
—
—
(
3.2
)
—
(
3.2
)
Other comprehensive loss, net of tax
—
—
—
—
(
12.3
)
(
12.3
)
Dividends paid ($
0.10
per share)
—
—
—
(
5.6
)
—
(
5.6
)
Issuances of common stock under stock-based compensation plan
32,123
—
—
—
—
—
Stock-based employee compensation expense
—
—
1.9
—
—
1.9
Stock issued to directors as compensation
—
—
0.1
—
—
0.1
Shares withheld for employee taxes
—
—
(
0.1
)
—
—
(
0.1
)
Balance, September 30, 2025
54,681,114
$
5.5
$
682.6
$
(
290.9
)
$
0.2
$
397.4
Balance, June 30, 2026
55,124,504
$
5.5
$
686.6
$
(
215.1
)
$
(
6.3
)
$
470.7
Net loss
—
—
—
(
1.2
)
—
(
1.2
)
Other comprehensive income, net of tax
—
—
—
—
1.2
1.2
Dividends paid ($
0.10
per share)
—
—
—
(
5.7
)
—
(
5.7
)
Issuances of common stock under stock-based compensation plan
30,326
—
—
—
—
—
Stock-based employee compensation expense
—
—
1.9
—
—
1.9
Stock issued to directors as compensation
37,167
—
0.3
—
—
0.3
Shares withheld for employee taxes
—
—
(
0.1
)
—
—
(
0.1
)
Balance, September 30, 2026
55,191,997
$
5.5
$
688.7
$
(
222.0
)
$
(
5.1
)
$
467.1
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
5
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
(in millions, except per share amounts)
(Unaudited)
Common Stock
Additional
Paid-In Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Shares
Amount
Total
Balance, December 31, 2024
54,335,830
$
5.4
$
675.7
$
164.3
$
13.1
$
858.5
Net loss
—
—
—
(
438.2
)
—
(
438.2
)
Other comprehensive loss, net of tax
—
—
—
—
(
12.9
)
(
12.9
)
Dividends paid ($
0.30
per share)
—
—
—
(
17.0
)
—
(
17.0
)
Issuances of common stock under stock-based compensation plan
280,367
0.1
—
—
—
0.1
Stock-based employee compensation expense
—
—
7.8
—
—
7.8
Stock issued to directors as compensation
18,614
—
0.5
—
—
0.5
Deferred compensation directors stock trust
46,303
—
—
—
—
—
Shares withheld for employee taxes
—
—
(
1.4
)
—
—
(
1.4
)
Balance, September 30, 2025
54,681,114
$
5.5
$
682.6
$
(
290.9
)
$
0.2
$
397.4
Balance, December 31, 2025
54,681,114
$
5.5
$
685.0
$
(
195.8
)
$
4.0
$
498.7
Net loss
—
—
—
(
9.3
)
—
(
9.3
)
Other comprehensive loss, net of tax
—
—
—
—
(
9.1
)
(
9.1
)
Dividends paid ($
0.30
per share)
—
—
—
(
16.9
)
—
(
16.9
)
Issuances of common stock under stock-based compensation plan
464,375
—
—
—
—
—
Stock-based employee compensation expense
—
—
5.3
—
—
5.3
Stock issued to directors as compensation
37,167
—
0.6
—
—
0.6
Deferred compensation directors stock trust
9,341
—
—
—
—
—
Shares withheld for employee taxes
—
—
(
2.2
)
—
—
(
2.2
)
Balance, September 30, 2026
55,191,997
$
5.5
$
688.7
$
(
222.0
)
$
(
5.1
)
$
467.1
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
6
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(Unaudited)
Nine Months Ended
September 30,
2026
2025
Operating
Net loss
$
(
9.3
)
$
(
438.2
)
Adjustments to reconcile Net loss to Net cash provided by operations:
Depreciation and amortization
102.7
106.3
Amortization of deferred issuance costs
4.7
6.2
Goodwill and other impairments
1.4
423.2
Deferred income tax
0.1
(
19.5
)
Pension and other postretirement benefits
(
3.5
)
(
2.9
)
Stock-based compensation
5.7
8.6
(Gain) loss on disposal of assets
0.5
(
0.8
)
(Gain) loss on foreign currency transactions
(
2.1
)
5.8
Loss on debt extinguishment
8.7
—
Other items, net
(
3.4
)
(
9.5
)
Changes in operating working capital:
Accounts receivable
(
33.2
)
(
34.3
)
Inventories
(
42.0
)
35.3
Prepaid expenses
1.8
(
0.4
)
Accounts payable and other current liabilities
75.0
37.1
Accrued income taxes
10.3
(
2.4
)
Net changes in operating working capital
11.9
35.3
Net cash provided by operations
117.4
114.5
Investing
Capital spending
(
26.9
)
(
28.7
)
Proceeds from disposal of assets
—
2.9
Cash received from settlement of cross-currency swap contracts
—
3.4
Other investing
(
0.1
)
(
0.6
)
Net cash used in investing
(
27.0
)
(
23.0
)
7
MATIV HOLDINGS, INC. AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in millions)
(Unaudited)
Nine Months Ended
September 30,
2026
2025
Financing
Cash dividends paid
(
17.0
)
(
16.8
)
Proceeds from long-term debt
705.7
64.0
Payments on long-term debt
(
728.1
)
(
131.1
)
Payments for debt issuance costs
(
32.7
)
—
Payments on financing lease obligations
(
2.5
)
(
2.5
)
Shares withheld for employee taxes
(
2.2
)
(
1.4
)
Net cash used in financing
(
76.8
)
(
87.8
)
Effect of exchange rate changes on Cash and cash equivalents and Restricted cash
(
1.9
)
4.9
Increase in Cash and cash equivalents and Restricted cash
11.7
8.6
Cash and cash equivalents and Restricted cash at beginning of period
89.8
94.3
Cash and cash equivalents and Restricted cash at end of period
$
101.5
$
102.9
Supplemental Cash Flow Disclosures
Cash paid for interest, net
$
52.5
$
55.2
Cash paid (received) for taxes, net
$
(
2.2
)
$
9.4
Capital spending in Accounts payable and Accrued expenses and other current liabilities
$
4.2
$
4.0
Insurance recoveries received
$
5.0
$
—
The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.
8
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1.
General
Nature of Business
Organization and operations
- Mativ Holdings, Inc. ("Mativ," "we," "our," or the "Company") is a global leader in specialty materials, solving our customers’ most complex challenges by engineering bold, innovative solutions that connect, protect, and purify our world. Mativ manufactures globally through our family of business-to-business and consumer product brands. Mativ targets premium applications across diversified and growing end-markets, from filtration to healthcare to sustainable packaging and more. Our broad portfolio of technologies combines polymers, fibers, and resins to optimize the performance of our customers’ products across multiple stages of the value chain.
Reportable Segments
- the Company has
two
reportable segments: (1) Filtration & Advanced Materials ("FAM"), focused primarily on filtration media and components, advanced films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions ("SAS") focused primarily on tapes, labels, liners, specialty paper, packaging and healthcare solutions.
Basis of Presentation
The accompanying unaudited condensed consolidated financial statements and the notes thereto have been prepared in accordance with the instructions on Form 10-Q and Rule 10-01 of Regulation S-X of the Securities and Exchange Commission ("SEC") and do not include all the information and disclosures required by accounting principles generally accepted in the United States of America ("GAAP"). However, such information reflects all adjustments (consisting of normal recurring adjustments) which are, in the opinion of management, necessary for a fair statement of results for the interim periods.
The results of operations for the three and nine months ended September 30, 2026 are not necessarily indicative of the results to be expected for the full year. The unaudited condensed consolidated financial statements and these notes thereto included herein should be read in conjunction with the audited consolidated financial statements and the related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, as filed with the SEC on February 26, 2026.
Reclassifications
Certain prior year amounts in the Consolidated Statements of Cash Flows have been reclassified to conform to the current year presentation for comparative purposes.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the revenues and expenses during the reporting period. Actual results could differ significantly from these estimates. The significant estimates underlying our unaudited condensed consolidated financial statements include, but are not limited to, inventory valuation, goodwill valuation, useful lives of tangible and intangible assets, stock-based compensation, derivatives, receivables valuation, pension, postretirement and other benefits, income taxes and contingencies.
R
eceivables Sales Agreement
The Company participates in an accounts receivables sales agreement (the “Receivables Sales Agreement”) to sell certain trade receivables arising from revenue transactions of the Company's U.S. subsidiaries on a revolving basis. On October 23, 2026, the Company amended the Receivable Sales Agreement to, among other things, extend the term until October 23, 2029.
9
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The amount of receivables pledged as collateral pursuant to our Receivables Sales Agreement as of September 30, 2026 and December 31, 2025 was $
28.6
million and $
27.2
million, respectively.
The following table summarizes the activity under the Receivables Sales Agreement (in millions):
Nine Months Ended
September 30,
2026
2025
Trade accounts receivable sold to financial institutions
$
837.3
$
797.7
Cash proceeds from financial institutions
$
836.9
$
797.2
For more information on the Receivables Sales Agreement, refer to Note 5. Accounts Receivable, net of our Form 10-K for the 2025 fiscal year ended December 31, 2025.
Recently Adopted Accounting Pronouncements
In July 2025, the FASB issued ASU 2025-05, "Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets." The ASU provides entities with a practical expedient to simplify the estimation of expected credit losses on current accounts receivable and current contract assets that arise from transactions accounted for under ASC 606, Revenue from Contracts with Customers, by allowing the assumption that current conditions as of the balance sheet date will not change during the remaining life of the asset. Adoption of the ASU, which is effective for annual reporting periods beginning after December 15, 2025, did not have a significant impact on the Company’s consolidated financial statements.
Recently Issued Accounting Pronouncements
In November 2024, the FASB issued ASU 2024-03, "Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures." The ASU requires a public business entity to provide disaggregated disclosures of certain categories of expenses on an annual and interim basis including purchases of inventory, employee compensation, depreciation, and intangible asset amortization for each income statement line item that contains those expenses. This ASU is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s disclosures.
In September 2025, the FASB issued ASU 2025-06, "Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software." The ASU modernizes existing internal use software guidance to adapt to concepts and processes present in an agile development environment. Key amendments include the elimination of software project development stages in favor of a requirement to commence capitalization once management has authorized the project, committed to funding, and project completion is probable. This ASU is effective for interim and annual reporting periods beginning after December 15, 2027 with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements.
In November 2025, the FASB issued ASU 2025-09, “Derivatives and Hedging (Topic 815): Hedge Accounting Improvements.” The ASU clarifies certain aspects of the guidance on hedge accounting and addresses several incremental hedge accounting issues arising from the global reference rate reform initiative (LIBOR sunset). The ASU further aligns hedge accounting with the economics of an entity’s risk management activities and better reflects hedging strategies in financial reporting by enabling entities to achieve and maintain hedge accounting for highly effective economic hedges of forecasting transactions. This ASU is effective for interim and annual reporting periods beginning after December 15, 2026, with early adoption permitted. Based on Mativ's existing hedging strategy, adoption of this ASU is not expected to have a significant impact on the Company’s consolidated financial statements.
10
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
In December 2025, the FASB issued ASU 2025-10, "Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities." This ASU provides recognition, measurement, presentation, and disclosure requirements for government grants. Under the new guidance, proceeds from government grants must be recognized in earnings during the same period the underlying costs associated with grant eligibility are incurred. However, grant income must not be recognized unless it is probable the grant will be received and the entity will comply with the conditions attached to the grant. This ASU is effective for interim and annual reporting periods beginning after December 15, 2028. Adoption of the ASU is not expected to have a significant impact on the Company’s consolidated financial statements.
In December 2025, the FASB issued ASU 2025-11, "Interim Reporting (Topic 270): Narrow-Scope Improvements." This ASU improves clarity for interim financial reporting requirements under the existing guidance within Accounting Standards Codification ("ASC") Topic 270, Interim Reporting, by creating a comprehensive list of interim disclosure requirements, clarifying scope and applicability, along with adding a principle to disclose all material events that have occurred since the most recently filed Form 10-K. This ASU is effective for interim and annual reporting periods beginning after December 15, 2027. Adoption of the ASU is not expected to have a significant impact on the Company's interim reporting.
In May 2026, the FASB issued ASU 2026-02, "Environmental Credits and Environmental Credit Obligations (Topic 818)". This ASU establishes recognition, measurement, presentation, and disclosure requirements for all entities that generate, purchase, or receive environmental credits. This ASU is effective retrospectively for interim and annual reporting periods beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating this ASU to determine its impact on the Company’s consolidated financial statements.
Note 2.
Other Comprehensive Income (Loss)
Comprehensive income (loss) includes Net loss, as well as items charged directly to stockholders' equity, which are excluded from Net loss. The Company has presented Comprehensive income (loss) in the unaudited Condensed Consolidated Statements of Comprehensive Income (Loss).
Components of Accumulated other comprehensive income (loss), net of tax, were as follows (in millions):
September 30,
2026
December 31, 2025
Accumulated pension and Other Post-Employment Benefits ("OPEB") liability adjustments
$
(
27.9
)
$
(
28.6
)
Accumulated unrealized gain on derivative instruments
0.6
1.6
Accumulated unrealized foreign currency translation adjustments
22.2
31.0
Accumulated other comprehensive income (loss), net of tax
$
(
5.1
)
$
4.0
Changes in the components of Accumulated other comprehensive income (loss), net of tax, were as follows (in millions):
Three Months Ended September 30,
2026
2025
Pre-tax
Net of
Tax
Pre-tax
Net of
Tax
Pension and OPEB liability adjustments
$
0.2
$
0.2
$
(
8.3
)
$
(
8.3
)
Derivative instrument adjustments
(
0.6
)
(
0.6
)
(
3.3
)
(
3.3
)
Unrealized foreign currency translation adjustments
1.6
1.6
(
1.0
)
(
0.7
)
Total
$
1.2
$
1.2
$
(
12.6
)
$
(
12.3
)
11
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Nine Months Ended September 30,
2026
2025
Pre-tax
Net of
Tax
Pre-tax
Net of
Tax
Pension and OPEB liability adjustments
$
0.6
$
0.7
$
(
8.3
)
$
(
8.2
)
Derivative instrument adjustments
(
1.0
)
(
1.0
)
(
15.1
)
(
15.1
)
Unrealized foreign currency translation adjustments
(
8.8
)
(
8.8
)
9.5
10.4
Total
$
(
9.2
)
$
(
9.1
)
$
(
13.9
)
$
(
12.9
)
Note 3.
Net Loss Per Share
The Company uses the two-class method to calculate Net loss per share. The Company has granted restricted stock that contains non-forfeitable rights to dividends on unvested shares. Since these unvested shares are considered participating securities under the two-class method, the Company allocates Net loss per share to common stock and participating securities according to dividends declared and participation rights in undistributed earnings.
Diluted net loss per common share is computed based on Net loss divided by the weighted average number of common and potential common shares outstanding. Potential common shares during the respective periods are those related to dilutive stock-based compensation, including long-term stock-based incentive compensation and directors’ accumulated deferred stock compensation, which may be received by the directors in the form of stock or cash.
A reconciliation of the average number of common and potential common shares outstanding used in the calculations of basic and diluted Net loss per share follows (in millions, shares in thousands):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Numerator (basic and diluted):
Net loss
$
(
1.2
)
$
(
3.2
)
$
(
9.3
)
$
(
438.2
)
Less: Dividends to participating securities
(
0.2
)
(
0.2
)
(
0.6
)
(
0.5
)
Net loss attributable to Common Stockholders
$
(
1.4
)
$
(
3.4
)
$
(
9.9
)
$
(
438.7
)
Denominator:
Average number of common shares outstanding
55,190.1
54,671.9
55,046.8
54,582.1
Effect of dilutive stock-based compensation
(1)
—
—
—
—
Average number of common and potential common shares outstanding
55,190.1
54,671.9
55,046.8
54,582.1
(1)
For the three and nine months ended September 30, 2026, Diluted loss per share excludes
780,000
and
800,000
weighted average potential common shares, respectively, as their inclusion would be anti-dilutive. For the three and nine months ended September 30, 2025, Diluted loss per share excludes
730,000
and
360,000
weighted average potential common shares, respectively, as their inclusion would be anti-dilutive.
12
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 4.
Inventories, Net
The following table summarizes inventories by major class (in millions):
September 30,
2026
December 31, 2025
Raw materials
$
125.7
$
115.8
Work in process
57.6
52.4
Finished goods
133.3
147.9
Supplies and other
12.5
13.0
Total inventories, net
$
329.1
$
329.1
Note 5.
Goodwill
The change in the carrying amount of goodwill (entirely attributable to the SAS reportable segment) was as follows (in millions):
Total
Balance at December 31, 2025
$
57.6
Foreign currency translation
(
1.4
)
Balance at September 30, 2026
$
56.2
Note 6.
Intangible Assets
The gross carrying amount and accumulated amortization for intangible assets as of September 30, 2026 and December 31, 2025 consisted of the following (in millions):
September 30, 2026
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Amortized Intangible Assets
Customer relationships
$
747.5
$
347.2
$
400.3
Acquired and developed technology
92.3
66.4
25.9
Trade names
48.7
15.3
33.4
Patents
1.9
1.9
—
Total
$
890.4
$
430.8
$
459.6
December 31, 2025
Gross
Carrying
Amount
Accumulated
Amortization
Net
Carrying
Amount
Amortized Intangible Assets
Customer relationships
$
758.0
$
313.8
$
444.2
Acquired and developed technology
93.3
59.7
33.6
Trade names
49.5
13.2
36.3
Patents
1.9
1.8
0.1
Total
$
902.7
$
388.5
$
514.2
13
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 7.
Restructuring and Other Impairment Activities
During the third quarter of 2026, Mativ centralized the support for common business practices across our organization within a new service center. Restructuring expenses across FAM, SAS, and Unallocated during the three months ended September 30, 2026 included severance charges associated with this transition.
Other impairment expense in the FAM segment was attributable to an impairment charge associated with long-lived assets at one of our North American facilities, which will be removed from service during the fourth quarter of 2026 as part of a product line rationalization. This expense was partially offset by an increase in the fair value of our assets held for sale to adjust the carrying value to the fair value of the assets less the cost to sell. The assets were subsequently sold, refer to Note 14. Subsequent Events for additional information.
The following table summarizes total restructuring and other impairment expense (in millions):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Filtration and Advanced Materials
(1)
Severance and termination benefits
$
0.1
$
0.7
$
0.2
$
2.8
Other exit costs
0.5
0.4
2.3
1.2
FAM restructuring expense
0.6
1.1
2.5
4.0
Sustainable and Adhesive Solutions
Severance and termination benefits
0.5
1.0
0.5
1.4
Other exit costs
—
—
—
0.1
SAS restructuring expense
0.5
1.0
0.5
1.5
Unallocated
Severance and termination benefits
0.3
—
0.3
1.4
Unallocated restructuring expense
0.3
—
0.3
1.4
Total restructuring expense
1.4
2.1
3.3
6.9
Filtration and Advanced Materials
Other impairment expense
1.3
6.0
1.4
11.3
Total restructuring and other impairment expense
$
2.7
$
8.1
$
4.7
$
18.2
(1)
Includes costs associated with facility closures initiated in prior years of $
0.5
million and $
0.4
million for the three months ended September 30, 2026 and 2025, respectively. Through September 30, 2026, the Company has recognized accumulated restructuring charges of $
7.9
million related to an asset held for sale. This site was sold on November 4, 2026, refer to Note 14. Subsequent Events for additional information. Mativ does not expect to incur additional costs associated with this facility.
The following table summarizes changes in restructuring liabilities (in millions):
2026
2025
Balance at beginning of the period
$
2.5
$
2.2
Charges for restructuring programs
3.3
6.9
Cash payments and other
(
3.4
)
(
4.9
)
Balance at end of the period
$
2.4
$
4.2
Restructuring liabilities were classified within Accrued expenses and other current liabilities and Other liabilities in the unaudited Condensed Consolidated Balance Sheets.
14
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Assets held for sale of $
6.8
million and $
5.0
million were included in Other current assets as of September 30, 2026 and December 31, 2025, respectively.
Note 8.
Debt
Total debt, net of debt issuance costs, is summarized in the following table (in millions):
September 30,
2026
December 31, 2025
Revolving facility - U.S. dollar borrowings
$
20.0
$
160.0
Term loan A facility
89.7
83.3
Term loan B facility
498.7
116.5
Delayed draw term loan
—
270.1
8.000
% Senior unsecured notes due October 1, 2029
400.0
400.0
Other loan agreements
2.7
3.7
Debt issuance costs
(
34.7
)
(
15.4
)
Total debt
976.4
1,018.2
Less: Current debt
(
3.8
)
(
2.9
)
Total long-term debt
$
972.6
$
1,015.3
Indenture for
8.000
% Senior Unsecured Notes Due 2029
On October 7, 2024, the Company closed a private offering of $
400.0
million of
8.000
% senior unsecured notes due 2029 (the “2029 Notes”). The 2029 Notes were sold in a private placement in reliance on Rule 144A and Regulation S under the Securities Act of 1933, as amended, pursuant to a purchase agreement between the Company, certain subsidiaries of the Company and a third-party financial institution, as representative of the initial purchasers. The 2029 Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by each of the Company’s existing and future wholly-owned subsidiaries that is a borrower under or that guarantees obligations under the Company’s senior secured credit facilities or that guarantees certain other indebtedness, subject to certain exceptions.
The 2029 Notes were issued pursuant to an Indenture (the “Indenture”), dated as of October 7, 2024, among the Company, the guarantors listed therein and a third-party financial institution, as trustee. Interest on the 2029 Notes is payable semi-annually in arrears on April 1 and October 1 of each year, beginning on April 1, 2025, and the 2029 Notes mature on October 1, 2029, subject to earlier repurchase or redemption.
The Company may redeem some or all of the 2029 Notes at any time on or after October 1, 2026, at the redemption prices set forth in the Indenture, together with accrued and unpaid interest, if any, to, but excluding, the redemption date. If the Company sells certain assets or consummates certain change of control transactions, the Company will be required to make an offer to repurchase the Notes, subject to certain conditions.
The Indenture contains certain covenants that, among other things, limit the Company’s ability and the ability of its restricted subsidiaries to incur additional indebtedness, make certain dividends, repurchase Company stock or make other distributions, make certain investments, create liens, transfer or sell assets, merge or consolidate and enter into transactions with the Company’s affiliates. Such covenants are subject to a number of exceptions and qualifications set forth in the Indenture. The Indenture also contains certain customary events of default, including failure to make payments in respect of the principal amount of the 2029 Notes, failure to make payments of interest on the 2029 Notes when due and payable, failure to comply with certain covenants and agreements and certain events of bankruptcy or insolvency. The Company was in compliance with all of its covenants under the Indenture at September 30, 2026.
15
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Credit Facility
On April 3, 2026, the Company entered into the Ninth Amendment (the “Amendment”) to its existing multicurrency credit agreement (as amended, the “Amended Credit Agreement”). The Amendment provided for a refinancing and restructuring of the Company’s existing credit facilities.
The Amended Credit Agreement replaced the Company’s prior revolving credit facility, Term Loan A facility and Term Loan B facility and eliminated the delayed draw term loan facility. The Amended Credit Agreement provides for a $
305.0
million revolving credit facility (the “Revolving Facility”), including sub-facilities for borrowings in Euros and Sterling, an $
89.9
million Term Loan A facility (the “Term Loan A Facility”), and a $
500.0
million Term Loan B facility (the “Term Loan B Facility”), resulting in total committed credit facilities of approximately $
894.9
million. The Company also recognized an $
8.7
million loss on debt extinguishment as a result of the transaction.
In connection with the Amendment, certain of the Company’s subsidiaries became additional U.S. borrowers, and another subsidiary became a guarantor under the Amended Credit Agreement.
The Revolving Facility and Term Loan A Facility mature on the earlier of (i)
five years
from April 3, 2026 or (ii)
182
days prior to the maturity of the Company’s
8.000
% senior notes due 2029. The Term Loan B Facility matures on the earlier of (i)
seven years
from April 3, 2026 or (ii)
91
days prior to the maturity of the Company’s 2029 Notes.
Borrowings under the Amended Credit Agreement bear interest at variable rates based on benchmark rates, including Term SOFR and EURIBOR (or successor rates), plus applicable margins. For the Revolving Facility and Term Loan A Facility, margins range from
1.75
% to
2.75
%, depending on the Company’s Net Debt to EBITDA ratio, with a commitment fee rate ranging from
0.15
% to
0.35
% at a current rate of
0.30
%. Term Loan B borrowings bear interest at fixed margins ranging from
3.50
% to
4.50
%, depending on the applicable benchmark rate.
The Amended Credit Agreement contains customary affirmative and negative covenants and financial maintenance covenants applicable to the Revolving Facility and Term Loan A Facility, including a minimum interest coverage ratio ranging from
2.50
x to
3.00
x over time, and a maximum Net Debt to EBITDA ratio ranging from
5.00
x to
4.00
x over time.
The Company was in compliance with all of its covenants under the Amended Credit Agreement at September 30, 2026.
Average Interest Rates
As of September 30, 2026, the average interest rate was
7.66
% on outstanding Revolving Facility borrowings,
6.40
% on outstanding Term Loan A Credit Facility borrowings, and
8.40
% on outstanding Term Loan B Facility borrowings. The effective rate on the 2029 Notes was
8.000
%.
Principal Repayments
The following is the expected maturities for the Company's debt obligations as of September 30, 2026 (in millions):
2026
$
2.2
2027
6.6
2028
6.1
2029
406.2
2030
6.2
Thereafter
583.8
Total
$
1,011.1
16
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Fair Value of Debt
At September 30, 2026 and December 31, 2025, the fair market value of the 2029 Notes was $
398.9
million and $
403.6
million, respectively. The fair market value for the 2029 Notes was determined using quoted market prices, which are directly observable Level 1 inputs. The fair market value of all other debt as of September 30, 2026 and December 31, 2025 approximated the respective carrying amounts as the interest rates approximate current market indices.
Note 9.
Derivatives
The Company utilizes a variety of practices including derivative instruments to manage risk associated with foreign currency exchange rate risk and interest rate risk on its variable-rate debt. The Company has no derivative instruments for trading or speculative purposes or derivatives with credit risk-related contingent features. All derivative instruments used by the Company are either exchange traded or are entered into with major financial institutions to reduce credit risk and risk of nonperformance by third parties. The fair values of the Company’s derivative instruments are determined using observable inputs and are considered Level 2 assets or liabilities.
Foreign Currency Risk Management
The Company utilizes currency forward and swap contracts to selectively hedge its exposure to foreign currency risk when it is practical and economical to do so. We may designate certain of our foreign currency hedges as cash flow hedges. Changes in the fair value of cash flow hedges are reported as a component of Accumulated other comprehensive income (loss), net of tax and reclassified into earnings when the forecasted transaction affects earnings. Changes in the fair value of foreign exchange contracts not designated as hedges are recorded to Net income (loss) each period.
The Company also uses cross-currency swap contracts to selectively hedge its exposure to foreign currency related changes in our net investments in certain foreign operations. We designate these cross-currency swap contracts as net investment hedges based on the spot rate of the EUR. Changes in the fair value of these hedges are deferred within the foreign currency translation component of Accumulated other comprehensive income (loss), net of tax and reclassified into earnings when the foreign investment is sold or substantially liquidated. Future changes in the components related to the spot change on the notional will be recorded in Other Comprehensive Income ("OCI") and remain there until the hedged subsidiaries are substantially liquidated. Gains and losses excluded from the assessment of hedge effectiveness are recognized in earnings (Interest expense) over the term of the swap. Gains and losses associated with the settlement of derivative instruments designated as a net investment hedge are classified within investing activities in the Condensed Consolidated Statement of Cash Flows. As of September 30, 2026 and December 31, 2025 the gross notional amount of outstanding cross-currency swap contracts designated as a net investment hedge wa
s €
450
million
.
Interest Rate Risk Management
The Company selectively hedges its exposure to interest rate increases on variable-rate, long-term debt when it is practical and economical to do so. Changes in the fair value of pay-fixed, receive-variable interest rate swap contracts considered cash flow hedges are reported as a component of Accumulated other comprehensive income (loss), net of tax and reclassified into earnings when the forecasted transaction affects earnings. The terms of the interest rate swaps mirror the terms of the underlying debt, including timing of the payments and interest rates. As of September 30, 2026 and December 31, 2025 the gross notional amounts of outstanding interest rate swaps designated as a cash flow hedge was
$
405.8
million and $480.8 million, respectively
.
17
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The following table presents the fair value of asset and liability derivatives and the respective balance sheet locations at September 30, 2026 (in millions):
Asset Derivatives
Liability Derivatives
Balance Sheet
Location
Fair
Value
Balance Sheet
Location
Fair
Value
Derivatives designated as hedges:
Foreign exchange contracts
Accounts receivable, net
$
2.6
Accounts payable
$
7.7
Foreign exchange contracts
Other assets
—
Other liabilities
27.6
Interest rate contracts
Accounts receivable, net
1.3
Accrued expenses and other current liabilities
—
Interest rate contracts
Other assets
3.4
Other liabilities
—
Total derivatives designated as hedges
7.3
35.3
Derivatives not designated as hedges:
Foreign exchange contracts
Accounts receivable, net
—
Accrued expenses and other current liabilities
0.1
Total derivatives not designated as hedges
—
0.1
Total derivatives
$
7.3
$
35.4
The following table presents the fair value of asset and liability derivatives and the respective balance sheet locations at December 31, 2025 (in millions):
Asset Derivatives
Liability Derivatives
Balance Sheet
Location
Fair
Value
Balance Sheet
Location
Fair
Value
Derivatives designated as hedges:
Foreign exchange contracts
Accounts receivable, net
$
1.1
Accrued expenses and other current liabilities
$
—
Foreign exchange contracts
Other assets
—
Other liabilities
53.2
Interest rate contracts
Other assets
1.1
Other liabilities
0.3
Total derivatives designated as hedges
2.2
53.5
Derivatives not designated as hedges:
Foreign exchange contracts
Accounts receivable, net
—
Accrued expenses and other current liabilities
0.1
Total derivatives not designated as hedges
—
0.1
Total derivatives
$
2.2
$
53.6
18
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Gains (losses) on derivatives designated as cash flow and net investment hedges recognized in other comprehensive income (loss) are summarized below (in millions) on a pretax basis:
Derivatives Designated in Hedging Relationships
Gains (Losses) Recognized in Accumulated Other Comprehensive Income (Loss)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Derivatives designated as cash flow hedge
Amounts included in assessment of effectiveness
$
1.6
$
0.5
$
5.5
$
(
3.6
)
Derivatives designated as net investment hedge
Amounts included in assessment of effectiveness
4.7
3.9
17.9
(
57.9
)
Total gain (loss)
$
6.3
$
4.4
$
23.4
$
(
61.5
)
The Company's designated derivative instruments are highly effective. As such, there were no gains or losses recognized immediately in income related to the hedge ineffectiveness or amounts excluded from hedge effectiveness testing for the three and nine months ended September 30, 2026 or 2025, other than those related to derivatives designated as a net investment hedge, noted below.
Gains (losses) on derivatives within the Condensed Consolidated Statement of Income (Loss) were as follows (in millions):
Location of Gains (Losses)
Amount of Gains (Losses) Recognized
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Effect of cash flow hedges
Amount reclassified from Accumulated other comprehensive income (loss) to income
Interest expense
$
2.2
$
3.8
$
6.5
$
11.5
Effect of net investment hedges
Amount excluded from assessment of hedge effectiveness
Interest expense
1.5
1.5
4.5
5.1
Effect of non-designated hedges
Foreign exchange contracts
Other income
(
1.0
)
(
1.2
)
(
1.4
)
3.7
Total gain
$
2.7
$
4.1
$
9.6
$
20.3
Deferred gains of $
4.9
million attributable to settled interest rate swaps designated as cash flow hedges are expected to be reclassified to Interest expense over the next twelve months.
Note 10.
Commitments and Contingencies
Other Commitments
On November 30, 2023, the Company completed the sale of its Engineered Papers business (the “EP Divestiture”) to Evergreen Hill Enterprise Pte. Ltd. (“Evergreen Hill Enterprise”). In connection with the EP Divestiture, we undertook to indemnify and hold Evergreen Hill Enterprise harmless from claims and liabilities related to the EP business that were identified as excluded or specified liabilities in the related agreements up to an amount not to exceed $
10
million. As of September 30, 2026, there were no material claims pending under this indemnification.
19
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Litigation
We are involved in various legal proceedings from time to time, including relating to contracts, commercial disputes, taxes, environmental issues, employment and workers' compensation claims, product liability and other matters. We periodically review the status of these proceedings with both inside and outside counsel. We believe that the ultimate disposition of these matters will not have a material effect on the results of operations in a given quarter or year.
Menasha Tornado
On July 27, 2026, a severe tornado and related weather event destroyed a third-party distribution facility engaged by the Company in Menasha, Wisconsin (the "Menasha Tornado"). The Company maintains insurance coverage for inventory losses and business interruption, subject to applicable deductibles, sublimits, and coverage determinations. The Company expects to recover inventory losses resulting from the Menasha Tornado under this coverage and has recorded an insurance recoveries receivable of $
38.0
million, as well as $
5.0
million recoveries received, which represent the cost basis of the inventory and site clean-up and other costs it believes to be probable to recover. Inventory write-off and related insurance recoveries receivable are presented on a net basis within the Changes in operating working capital section of the Condensed Consolidated Statements of Cash Flows.
Recoveries in excess of the inventory losses, if any, including business interruption costs, are being pursued and will not be recognized in the financial statements until all uncertainties of timing and amount have been resolved.
(Amounts in millions)
Three and Nine Months Ended September 30, 2026
Write-off of inventory
$
42.5
Site clean-up and other costs
1.3
Total expense
43.8
Insurance recoveries received
5.0
Insurance recoveries receivable
(1)
38.0
Loss from natural disaster, net of insurance recoveries
$
0.8
(1)
The insurance recoveries receivable is recorded in Accounts receivable, net in the Consolidated Balance Sheets.
Environmental Matters
The Company's operations are subject to various nations' federal, state and local laws, regulations and ordinances relating to environmental matters. The nature of the Company's operations exposes it to the risk of claims with respect to various environmental matters, and there can be no assurance that material costs or liabilities will not be incurred in connection with such claims. While the Company has incurred in the past several years, and will continue to incur, capital and operating expenditures in order to comply with environmental laws and regulations, it believes that its future cost of compliance with environmental laws, regulations and ordinances, and its exposure to liability for environmental claims and its obligation to participate in the remediation and monitoring of certain hazardous waste disposal sites, will not have a material effect on its financial condition or results of operations. However, future events, such as changes in existing laws and regulations, or unknown contamination or costs of remediation of sites owned, operated or used for waste disposal by the Company (including contamination caused by prior owners and operators of such sites or other waste generators) may give rise to additional costs which could have a material effect on its financial condition or results of operations.
20
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Employees and Labor Relations
As of September 30, 2026, approximately
27
% of the Company's U.S. workforce and
35
% of its non-U.S. workforce are under collective bargaining agreements. Approximately
0
% of all U.S. employees and
11
% of non-U.S. employees are under collective bargaining agreements that will expire in the next 12 months.
For the non-U.S. workforce, union membership is voluntary and does not need to be disclosed to the Company under local laws. As a result, the number of employees covered by the collective bargaining agreements in some countries cannot be determined.
General Matters
In the ordinary course of conducting business activities, the Company and its subsidiaries become involved in certain other judicial, administrative and regulatory proceedings involving both private parties and governmental authorities. These proceedings include insured and uninsured regulatory, employment, intellectual property, general and commercial liability, environmental and other matters. At this time, the Company does not expect any of these proceedings to have a material effect on its reputation, business, financial condition, results of operations or cash flows. However, the Company can give no assurance that the results of any such proceedings will not materially affect its reputation, business, financial condition, results of operations or cash flows.
Note 11.
Postretirement and Other Benefits
The Company sponsors a number of different defined contribution retirement plans, alternative retirement plans and/or defined benefit pension plans across its operations. Defined benefit pension plans are sponsored in the United States, France, United Kingdom, Germany, Italy, and Canada and OPEB benefits related to post-retirement healthcare and life insurance are sponsored in the United States, Germany, and Canada. As of September 30, 2026, retained contributions of $
4.2
million related to our UK Pension scheme are included in Restricted cash. The use of these funds is limited to obligations associated with the scheme.
Pension and Other Benefits
The components of net pension cost (benefit) during the three months ended September 30, 2026 and 2025 were as follows (in millions):
Pension Benefits
Other Post-employment Plans
U.S.
Non-U.S.
U.S.
Non-U.S.
Three Months Ended September 30,
2026
2025
2026
2025
2026
2025
2026
2025
Service cost
$
0.2
$
0.2
$
0.1
$
0.3
$
0.1
$
—
$
0.2
$
0.3
Interest cost
3.3
4.1
2.0
2.0
0.1
0.3
0.1
0.1
Expected return on plan assets
(
4.0
)
(
4.6
)
(
1.5
)
(
1.3
)
—
—
—
—
Amortizations and other
—
—
0.1
—
—
—
—
—
Settlement loss
—
3.6
—
—
—
—
—
—
Net pension cost (benefit)
$
(
0.5
)
$
3.3
$
0.7
$
1.0
$
0.2
$
0.3
$
0.3
$
0.4
21
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
The components of net pension cost (benefit) during the nine months ended September 30, 2026 and 2025 were as follows (in millions):
Pension Benefits
Other Post-employment Plans
U.S.
Non-U.S.
U.S.
Non-U.S.
Nine Months Ended September 30,
2026
2025
2026
2025
2026
2025
2026
2025
Service cost
$
0.7
$
0.8
$
0.7
$
0.8
$
0.1
$
0.1
$
0.8
$
0.9
Interest cost
9.9
12.8
5.8
6.0
0.6
0.7
0.1
0.1
Expected return on plan assets
(
12.2
)
(
14.3
)
(
4.6
)
(
3.9
)
—
—
—
—
Amortizations and other
—
—
0.4
—
—
—
—
—
Settlement loss
—
3.6
—
—
—
—
—
—
Net pension cost (benefit)
$
(
1.6
)
$
2.9
$
2.3
$
2.9
$
0.7
$
0.8
$
0.9
$
1.0
The components of net pension cost (benefit) other than the service cost component are included in Other income (expense), net in the unaudited Condensed Consolidated Statements of Income (Loss).
The Company's cost under the qualified defined contribution retirement plans was $
3.8
million and $
3.6
million, respectively, for the three months ended September 30, 2026 and 2025 and $
11.7
million and $
11.0
million, respectively, for the nine months ended September 30, 2026 and 2025.
Note 12.
Income Taxes
The Company's effective tax rate was
185.7
% and
42.9
% for the three months ended September 30, 2026 and 2025, respectively. The net change was primarily due to mix of earnings and certain jurisdictions with a full valuation allowance in the current period. The Company's effective tax rate was (
1760.0
)% and
3.2
% for the nine months ended September 30, 2026 and 2025, respectively. The net change was primarily due to mix of earnings and certain jurisdictions with a full valuation allowance in the current period, and a goodwill impairment not deductible for tax purposes and valuation allowance changes in the prior period. The Company has historically calculated the provision or benefit for income taxes during interim reporting periods by applying an estimate of the annual effective tax rate for the full fiscal year to “ordinary” income or loss (pre-tax income or loss excluding unusual or infrequently occurring discrete items) for the reporting period. The Company determined that since small changes in estimated “ordinary” income would result in significant changes in the estimated annual effective tax rate, the historical method would not provide a reliable estimate for the three months, and nine months ended September 30, 2026. Accordingly, Mativ used a discrete effective tax rate method to calculate taxes for the three months, and nine months ended September 30, 2026.
Prior to the passage of the Tax Cuts and Jobs Act of 2017 ("Tax Act"), the Company asserted that substantially all of the undistributed earnings of its foreign subsidiaries were considered indefinitely reinvested and accordingly, no deferred taxes were provided. Due to the Tax Act, the Company has significant earnings and profits from its foreign subsidiaries that it can generally repatriate free of U.S. federal tax. As a result of the Company’s treasury policy to simplify and expedite its intercompany cash flows, as evidenced by the use of cash pooling, and in light of the Company’s prioritization of debt reduction and funding future growth, the Company does not assert indefinite reinvestment to the extent of each controlled foreign corporation's earnings and profits and to the extent of any foreign partnership’s U.S. tax capital accounts. As a result, the Company has provided for non-U.S. withholding taxes, U.S. federal tax related to currency movement on previously taxed earnings and profits, and U.S. state taxes on unremitted earnings.
All unrecognized tax positions could impact the Company's effective tax rate if recognized. There have been no material changes to the Company’s unrecognized tax positions for the three and nine months ended September 30, 2026. With respect to penalties and interest incurred from income tax assessments or related to unrecognized tax benefits, the Company’s policy is to classify penalties as provision for income taxes and interest as interest expense in its unaudited Condensed Consolidated Statements of Income (Loss). There were
no
material income tax penalties or interest accrued during the three and nine months ended September 30, 2026 or 2025.
22
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Many jurisdictions in which the Company operates have implemented Pillar Two legislation, and others are considering implementation of Pillar Two rules. While such new rules introduce complexity into the Company’s calculation of income tax expense, Pillar Two does not have a material impact as of the third quarter of 2026. Due to the novelty and complexity of Pillar Two, the Company continues to monitor for advancements and further guidance in Pillar Two rules, considering impacts of such developments on its tax expense.
Note 13.
Segment Information
The Company has
two
reportable segments: Filtration & Advanced Materials ("FAM") and Sustainable & Adhesive Solutions ("SAS").
FAM is focused primarily on filtration media and components, advanced films, coating and converting solutions, and extruded mesh products.
The FAM segment supplies customers directly, serving a diverse set of generally high-growth end markets. FAM end markets include water and air purification, life sciences, industrial processes, transportation, aerospace and defense, glass and glazing, packaging, agriculture, building and construction, safety and security.
SAS is focused primarily on tapes, labels, liners, specialty paper, packaging and healthcare solutions. The SAS segment supplies customers through distribution and directly, serving
growing and mature end markets including building and construction, DIY, product packaging, consumer & commercial papers, personal care, advanced wound care, medical device fixation and medical packaging.
The accounting policies of the reportable segments are the same as those described in Note 2. Summary of Significant Accounting Policies in the notes to the consolidated financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, 2025.
Our Chief Operating Decision Maker ("CODM") is our President and Chief Executive Officer. Effective January 1, 2026, Gross Profit has replaced Operating profit as the GAAP performance metric the CODM considers when making resource allocation decisions for each segment.
23
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Segment Results
The CODM primarily evaluates segment performance and allocates resources based on Gross profit. Assets are managed on a company-wide basis and, as such, are not disclosed at the segment level.
Net sales, Cost of products sold, Gross profit, and Depreciation (classified as Cost of products sold) by segment were (in millions):
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Net sales
FAM
$
218.5
$
198.3
$
608.5
$
590.3
SAS
281.0
315.4
902.4
933.6
Consolidated
$
499.5
$
513.7
$
1,510.9
$
1,523.9
Cost of products sold
FAM
$
167.0
$
155.8
$
469.7
$
466.8
SAS
234.8
258.5
745.3
781.4
Consolidated
$
401.8
$
414.3
$
1,215.0
$
1,248.2
Gross profit
FAM
$
51.5
$
42.5
$
138.8
$
123.5
SAS
46.2
56.9
157.1
152.2
Consolidated
$
97.7
$
99.4
$
295.9
$
275.7
Depreciation (classified as Cost of products sold)
FAM
$
6.0
$
6.7
$
18.6
$
20.0
SAS
10.7
11.3
33.7
36.4
Consolidated
$
16.7
$
18.0
$
52.3
$
56.4
Segment Net sales are attributed to the following geographic locations of the Company’s direct customers during the three months ended September 30, 2026 and 2025 were as follows (in millions):
Three Months Ended September 30,
2026
2025
FAM
SAS
Total
FAM
SAS
Total
United States
$
124.2
$
161.5
$
285.7
$
107.2
$
184.6
$
291.8
Europe
49.9
75.1
125.0
49.6
86.8
136.4
Asia-Pacific
32.8
20.7
53.5
28.9
19.8
48.7
Americas (excluding U.S.)
7.1
16.6
23.7
7.3
17.5
24.8
Other foreign countries
4.5
7.1
11.6
5.3
6.7
12.0
Net sales
$
218.5
$
281.0
$
499.5
$
198.3
$
315.4
$
513.7
24
MATIV HOLDINGS, INC. AND SUBSIDIARIES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Segment Net sales are attributed to the following geographic locations of the Company’s direct customers during the nine months ended 2026 and 2025 were as follows (in millions):
Nine Months Ended September 30,
2026
2025
FAM
SAS
Total
FAM
SAS
Total
United States
$
338.3
$
523.7
$
862.0
$
320.2
$
541.5
$
861.7
Europe
147.6
242.4
390.0
145.8
255.8
401.6
Asia-Pacific
88.1
64.4
152.5
87.6
57.4
145.0
Americas (excluding U.S.)
20.7
50.6
71.3
20.9
54.6
75.5
Other foreign countries
13.8
21.3
35.1
15.8
24.3
40.1
Net sales
$
608.5
$
902.4
$
1,510.9
$
590.3
$
933.6
$
1,523.9
Net sales as a percentage by product category for the business were as follows:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Filtration & netting
26
%
26
%
25
%
26
%
Advanced films
17
%
13
%
15
%
13
%
Tapes, labels & liners
30
%
29
%
30
%
29
%
Paper & packaging
14
%
17
%
16
%
17
%
Healthcare & other
13
%
15
%
14
%
15
%
Net sales
100
%
100
%
100
%
100
%
For more information on our Product Categories and the nature, timing and uncertainties associated with revenues and associated cash flows, refer to Note 3. Revenue Recognition of our Form 10-K for the 2025 fiscal year ended December 31, 2025.
Note 14.
Subsequent Events
On October 23, 2026, we entered into an amendment to the Receivables Sales Agreement. Refer to Note 1. General for additional information.
On November 4, 2026, the Company sold a facility in North America, which was classified as held for sale. The Company recognized the related increase in the carrying value, to the fair value of the assets less the cost to sell, in the three months ended September 30, 2026.
25
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
The following is a discussion of our financial condition and results of operations. This discussion should be read in conjunction with our unaudited condensed consolidated financial statements and related notes included elsewhere in this report and the audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2025. The discussion of our financial condition and results of operations includes various forward-looking statements about our markets, the demand for our products and our future prospects. These statements are based on certain assumptions we consider reasonable. For information about risks and exposures relating to us and our business, you should read the section entitled "Risk Factors" in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2025, the section entitled "Forward-Looking Statements" at the end of this Item 2 and the section entitled “Risk Factors” at Part II, Item 1A hereof. Unless the context indicates otherwise, references to "Mativ," "we," "us," "our," the "Company" or similar terms include Mativ Holdings, Inc. and our consolidated subsidiaries.
This Management's Discussion and Analysis of Financial Condition and Results of Operations ("MD&A") is designed to provide a reader of our financial statements with an understanding of our recent performance, our financial condition and our prospects. This MD&A discusses the financial condition and results of operations of the Company as of and for the three and nine months ended September 30, 2026.
Recent Developments
Throughout 2025 and 2026, the U.S. government proposed the implementation of, or did implement, a number of tariffs on imports to the United States from a large number of countries. On February 20, 2026, the U.S. Supreme Court issued a ruling invalidating tariffs imposed under the International Emergency Economic Powers Act ("IEEPA"), and on April 20, 2026, the U.S. Customs and Border Protection ("U.S. CBP") launched a refund platform. The net impact of IEEPA tariff refund claims submitted and accepted by U.S. CBP as of September 30, 2026 was not significant. The Company continues to monitor developments with respect to tariffs and trade policy, including refund initiatives and other opportunities to mitigate the related impacts, costs and other effects of tariffs.
SUMMARY
Three Months Ended
September 30,
Percent of Net Sales
Nine Months Ended
September 30,
Percent of Net Sales
(in millions, except per share amounts)
2026
2025
2026
2025
2026
2025
2026
2025
Net sales
$
499.5
$
513.7
100.0
%
100.0
%
$
1,510.9
$
1,523.9
100.0
%
100.0
%
Gross profit
$
97.7
$
99.4
19.6
%
19.3
%
$
295.9
$
275.7
19.6
%
18.1
%
Restructuring & other impairment expense
$
2.7
$
8.1
0.5
%
1.6
%
$
4.7
$
18.2
0.3
%
1.2
%
Operating profit (loss)
$
19.9
$
16.0
4.0
%
3.1
%
$
62.5
$
(394.5)
4.1
%
(25.9)
%
Interest expense
$
18.1
$
17.7
3.6
%
3.4
%
$
54.9
$
54.1
3.6
%
3.6
%
Net loss
$
(1.2)
$
(3.2)
(0.2)
%
(0.6)
%
$
(9.3)
$
(438.2)
(0.6)
%
(28.8)
%
Diluted loss per share
$
(0.03)
$
(0.06)
$
(0.18)
$
(8.04)
Cash provided by operations
$
48.5
$
72.8
$
117.4
$
114.5
Capital spending
$
11.0
$
6.1
$
26.9
$
28.7
26
RESULTS OF OPERATIONS
Comparison of the Three Months Ended September 30, 2026 and 2025
Net Sales, Cost of Products Sold, and Gross Profit
The following table presents net sales, costs of products sold, and gross profit by segment for the three months ended September 30, 2026 and 2025 (in millions):
Three Months Ended
September 30,
Percent Change
Percent of Net Sales
2026
2025
Change
2026
2025
Net sales
FAM
$
218.5
$
198.3
$
20.2
10.2
%
SAS
281.0
315.4
(34.4)
(10.9)
%
Total Net sales
$
499.5
$
513.7
$
(14.2)
(2.8)
%
Cost of products sold
FAM
$
167.0
$
155.8
$
11.2
7.2
%
76.4
%
78.6
%
SAS
234.8
258.5
(23.7)
(9.2)
%
83.6
%
82.0
%
Total Cost of products sold
$
401.8
$
414.3
$
(12.5)
(3.0)
%
80.4
%
80.7
%
Gross profit
FAM
$
51.5
$
42.5
$
9.0
21.2
%
23.6
%
21.4
%
SAS
46.2
56.9
(10.7)
(18.8)
%
16.4
%
18.0
%
Total Gross profit
$
97.7
$
99.4
$
(1.7)
(1.7)
%
19.6
%
19.3
%
The following table presents components of change in net sales by segment for the three months ended September 30, 2026 compared to 2025 (as a percentage of net sales):
Percent Change in Net Sales
FAM
SAS
Total
Volume/mix
7.8
%
(13.8)
%
(5.4)
%
Sales associated with exited facilities
(1.2)
—
(0.5)
Total volume/mix
6.6
(13.8)
(5.9)
Selling price
3.9
3.6
3.7
Currency translation
(0.3)
(0.7)
(0.6)
Total percent change
10.2
%
(10.9)
%
(2.8)
%
FAM segment net sales increased primarily due to higher volume/mix and higher selling prices. This increase was partially offset by the impact from an exited facility and unfavorable currency translation.
SAS segment net sales d
ecreased, reflecting lower volume/mix primarily due to the impact of the Menasha Tornado and in our Healthcare business and un
favorable currency translation, partially offset by higher selling prices.
FAM gross profit increased, reflecting higher volume/mix and favorable price vs. cost performance, partially offset by increases in manufacturing costs.
SAS gross profit decreased, reflecting lower volume/mix and higher distribution expenses, partially offset by favorable price vs. cost performance.
27
Nonmanufacturing Expenses
The following table presents nonmanufacturing expenses for the three months ended September 30, 2026 and 2025 (in millions):
Three Months Ended
September 30,
Percent Change
Percent of Net Sales
2026
2025
Change
2026
2025
Selling and general expense
$
54.8
$
53.7
$
1.1
2.0
%
11.0
%
10.5
%
Research and development expense
4.8
5.6
(0.8)
(14.3)
%
1.0
%
1.1
%
Intangible asset amortization expense
15.5
16.0
(0.5)
(3.1)
%
3.1
%
3.1
%
Nonmanufacturing expenses
$
75.1
$
75.3
$
(0.2)
(0.3)
%
15.0
%
14.7
%
Nonmanufacturing expenses are generally in line with the prior period and include an increase to selling and general expense partially offset by a decrease to research and development expense .
Restructuring and Other Impairment Expense
The following table presents restructuring and other impairment expense for the three months ended September 30, 2026 and 2025 (in millions):
Three Months Ended
Percent of Net Sales
September 30, 2026
September 30, 2025
Change
2026
2025
Filtration & Advanced Materials
$
1.9
$
7.1
$
(5.2)
0.9
%
3.6
%
Sustainable & Adhesive Solutions
0.5
1.0
(0.5)
0.2
%
0.3
%
Unallocated expenses
0.3
—
0.3
Total
$
2.7
$
8.1
$
(5.4)
0.5
%
1.6
%
Restructuring and other impairment expenses decreased primarily due to higher impairment and severance charges incurred in the prior period, along with an increase in the fair value of an asset held for sale in the current period. This decrease was partially offset by an other impairment expense incurred in the current period related to a product line rationalization.
Interest Expense
Interest expense of $18.1 million during the three months ended September 30, 2026 increased $0.4 million, or 2.3%, compared to the prior year period.
Other Expense, Net
Other expense was $0.4 million during the three months ended September 30, 2026, compared to the prior year period expense of $3.9 million. The decrease was attributed to pension costs incurred in the prior period and foreign currency losses in the prior period.
Income Taxes
A $2.6 million income tax expense in the three months ended September 30, 2026 resulted in an effective tax rate of 185.7% compared with 42.9% in the prior year period. The Company's effective tax rate for the quarter was impacted by mix of earnings and certain jurisdictions with a full valuation allowance.
28
Net Loss and Net Loss per Share
Net loss during the three months ended September 30, 2026 was $1.2 million, or $0.03 per diluted share, compared with net loss of $3.2 million, or $0.06 per diluted share, during the prior-year quarter.
RESULTS OF OPERATIONS
Comparison of the Nine Months Ended September 30, 2026 and 2025
Net Sales, Cost of Products Sold, and Gross Profit
The following table presents Net sales, Cost of products sold, and Gross profit by segment (in millions):
Nine Months Ended
September 30,
Percent Change
Percent of Net Sales
2026
2025
Change
2026
2025
Net sales
FAM
$
608.5
$
590.3
$
18.2
3.1
%
SAS
902.4
933.6
(31.2)
(3.3)
%
Total Net sales
$
1,510.9
$
1,523.9
$
(13.0)
(0.9)
%
Cost of products sold
FAM
$
469.7
$
466.8
$
2.9
0.6
%
77.2
%
79.1
%
SAS
745.3
781.4
(36.1)
(4.6)
%
82.6
%
83.7
%
Total Cost of products sold
$
1,215.0
$
1,248.2
$
(33.2)
(2.7)
%
80.4
%
81.9
%
Gross profit
FAM
$
138.8
$
123.5
$
15.3
12.4
%
22.8
%
20.9
%
SAS
157.1
152.2
4.9
3.2
%
17.4
%
16.3
%
Total Gross profit
$
295.9
$
275.7
$
20.2
7.3
%
19.6
%
18.1
%
The following table presents components of change in net sales by segment for the nine months ended September 30, 2026 compared to 2025 (as a percentage of net sales):
Percent Change in Net Sales
FAM
SAS
Total
Volume/mix
1.2
%
(7.1)
%
(3.9)
%
Sales associated with exited facilities
(1.4)
—
(0.5)
Total volume/mix
(0.2)
(7.1)
(4.4)
Selling price
2.1
2.9
2.5
Currency translation
1.2
0.9
1.0
Total percent change
3.1
%
(3.3)
%
(0.9)
%
FAM segment net sales increased primarily due to higher selling prices, higher volume/mix, and favorable currency translation, partially offset by the impact from an exited facility.
SAS segment net sales decreased, reflecting lower volume/mix including t
he impact from the Menasha Tornado and in our Healthcare business, partially offset by higher selling prices and favorable
currency translation.
29
FAM gross profit increased, reflecting favorable price vs. cost performance, favorable currency, and higher volume/mix.
SAS gross profit increased, reflecting favorable price vs. cost performance, partially offset by lower volume/mix, higher distribution and manufacturing costs, and unfavorable currency.
Nonmanufacturing Expenses
The following table presents nonmanufacturing expenses (in millions):
Nine Months Ended
September 30,
Percent Change
Percent of Net Sales
2026
2025
Change
2026
2025
Selling and general expense
$
166.2
$
174.2
$
(8.0)
(4.6)
%
11.0
%
11.4
%
Research and development expense
15.2
18.6
(3.4)
(18.3)
%
1.0
%
1.2
%
Intangible asset amortization expense
47.3
47.3
—
N.M.
3.1
%
3.1
%
Nonmanufacturing expenses
$
228.7
$
240.1
$
(11.4)
(4.7)
%
15.1
%
15.8
%
Nonmanufacturing expenses decreased due to lower selling and general expense and research and development expense, primarily as a result of actions taken under our organizational realignment initiative (the "Plan"). The actions for R&D were focused on project prioritization and resource optimization.
Restructuring and Other Impairment Expense
The following table presents restructuring and other impairment expense by segment (in millions):
Nine Months Ended
September 30,
Percent of Net Sales
2026
2025
Change
2026
2025
Filtration & Advanced Materials
$
3.9
$
15.3
$
(11.4)
0.6
%
2.6
%
Sustainable & Adhesive Solutions
0.5
1.5
(1.0)
0.1
%
0.2
%
Unallocated expenses
0.3
1.4
(1.1)
Total
$
4.7
$
18.2
$
(13.5)
0.3
%
1.2
%
Restructuring and other impairment expenses decreased primarily due to higher impairment and severance charges incurred in the prior period, along with an increase in the fair value of an asset held for sale in the current period. This decrease was partially offset by an other impairment expense incurred in the current period related to a product line rationalization.
Interest Expense
Interest expense of $54.9 million during the nine months ended September 30, 2026 increased $0.8 million, or 1.5%, compared to the prior year period.
Other Income (Expense), Net
Other income was $0.6 million during the nine months ended September 30, 2026, compared to the prior year period expense of $4.2 million. The change was driven by foreign currency in both periods and pension costs incurred in the prior period, partially offset by gains on asset disposals in the prior period.
30
Income Taxes
An $8.8 million income tax expense in the nine months ended September 30, 2026 resulted in an effective tax rate of (1760.0)% compared with 3.2% in the prior year period. The Company’s effective tax rate was impacted by mix of earnings and certain jurisdictions with a full valuation allowance.
In the prior period, a one-time valuation allowance benefit of $23.5 million offset by a valuation allowance expense of $8.5 million was recorded against certain deferred tax assets and liabilities, as well as a $411.9 million goodwill impairment not deductible for tax.
Net Loss and Net Loss per Share
Net loss during the nine months ended September 30, 2026 was $9.3 million, or $(0.18) per diluted share, compared to net loss of $438.2 million, or $(8.04) per diluted share, during the prior year period.
LIQUIDITY AND CAPITAL RESOURCES
Liquidity and Cash Flow
A major factor in our liquidity and capital resource planning is our generation of cash flow from operations, which is sensitive to changes in the mix of products sold, volume and pricing of our products, as well as changes in our production volumes, costs and working capital. Our liquidity is supplemented by funds available under our Revolving Facility with a syndicate of banks that is used as either operating conditions or strategic opportunities warrant and also by our Receivables Sales Agreement, refer to Note 1. General for additional information.
Cash Requirements
As of September 30, 2026, $72.7 million of the Company's $97.3 million of Cash and cash equivalents was held by foreign subsidiaries. Restricted cash of $4.2 million primarily represents retained contributions associated with our UK Pension scheme, the use of which is restricted to obligations related to the scheme. We believe our sources of liquidity and capital, including cash on-hand, cash generated from operations, our Revolving Facility, and our Receivables Sales Agreement (an off-balance sheet arrangement as defined in Item 303(a)(4)(ii) of SEC Regulation S-K), will be sufficient to finance our continued operations, our current and long-term growth plan, and dividend payments.
The following table presents summarized activity related to our cash flow (in millions):
Nine Months Ended
September 30,
2026
2025
Net cash provided by (used in):
Operations
$
117.4
$
114.5
Investing
(27.0)
(23.0)
Financing
(76.8)
(87.8)
Effect of exchange rate changes on Cash and cash equivalents and Restricted cash
(1.9)
4.9
Net change in Cash and cash equivalents and Restricted cash
11.7
8.6
Cash and cash equivalents and Restricted cash at beginning of period
89.8
94.3
Cash and cash equivalents and Restricted cash at end of period
$
101.5
$
102.9
Net cash provided by operations increased $2.9 million to $117.4 million for the nine months ended September 30, 2026, compared with cash provided by operations of $114.5 million in the prior year. The increase was attributable to a lower net loss, adjusted for non-cash items, partially offset by unfavorable year-over-year movements in working capital related cash flows.
31
During the nine months ended September 30, 2026, net changes in operating working capital resulted in cash inflows of $11.9 million, compared to $35.3 million of inflows during the prior year period. The $23.4 million change was driven by outflows associated with inventory, partially offset by accounts payable and other current liabilities, and accrued income taxes.
Cash used in investing activities increased $4.0 million during the nine months ended September 30, 2026 compared to the prior year and was attributable to proceeds from sale of assets and cash received from settlement of swap contracts in the prior year, offset by lower capital spending in the current year.
Cash used in financing activities decreased $11.0 million during the nine months ended September 30, 2026 compared to the prior year. The decrease was attributable to the refinancing of the Company's Credit Agreement during April of 2026.
The Company presently believes the sources of liquidity discussed above are sufficient to meet our anticipated funding needs for the foreseeable future.
Dividend Payments
On November 4, 2026, we announced a cash dividend of $0.10 per share payable on December 18, 2026 to stockholders of record as of November 27, 2026. The Company is subject to covenants, discussed below, which require that we maintain certain financial ratios none of which under normal business conditions materially limit our ability to pay such dividends. We will continue to assess our dividend policy in light of our overall strategy, cash generation, debt levels and ongoing requirements for cash to fund operations and to pursue possible strategic opportunities.
Debt Instruments and Related Covenants
As of September 30, 2026, the Company had $976.4 million of total debt, $97.3 million of Cash and cash equivalents, $4.2 million of Restricted cash, and $276.2 million of undrawn capacity on its $305.0 million Revolving Facility. Per the terms of the Company's Amended Credit Agreement, net leverage was 3.8x at the end of the third quarter, versus a current maximum covenant ratio of 5.00x.
As of September 30, 2026, the Company’s nearest debt maturity is the 8.000% $400.0 million senior notes due October 1, 2029.
The following table presents activity related to our debt instruments for the nine months ended September 30, 2026 and 2025 (in millions):
Nine Months Ended
September 30,
2026
2025
Proceeds from long-term debt
$
705.7
$
64.0
Payments on long-term debt
(728.1)
(131.1)
Net payments from borrowings
$
(22.4)
$
(67.1)
The Company was in compliance with all of its covenants under the amended Credit Agreement at September 30, 2026. With the current level of borrowing and forecasted results, we expect to remain in compliance with our amended Credit Agreement financial covenants.
Our total debt to capital ratios, as calculated under the amended Credit Agreement, at September 30, 2026 and December 31, 2025 were 67.6% and 67.1%, respectively.
32
Critical Accounting Policies and Estimates
The preparation of our unaudited condensed consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States requires management to make judgments, assumptions and estimates that affect the amounts reported. There have been no material changes to the critical accounting policies and estimates described in our Form 10-K for the 2025 fiscal year ended December 31, 2025.
For further information about our critical accounting policies, please see the discussion of critical accounting policies in our Annual Report on Form 10-K for the year ended December 31, 2025 in the section captioned "Management's Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Estimates."
FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the "Act") that are subject to the safe harbor created by the Act and other legal protections. Forward-looking statements include, without limitation, those regarding our expectations related to the impact of tariffs, the incurrence of additional debt and expected maturities of the Company’s debt obligations, the adequacy of our sources of liquidity and capital, the cost and timing of our restructuring actions, the impact of ongoing litigation matters and environmental claims, the amount of capital spending and/or common stock repurchases, future cash flows, impacts and timing of our cost-reduction and cost-optimization initiatives, profitability, and cash flow, and other statements generally identified by words such as "believe," "expect," "intend," "guidance," "plan," "forecast," "potential," "anticipate," "confident," "project," "appear," "future," "should," "likely," "could," "may," "will," "typically" and similar words.
These forward-looking statements are prospective in nature and not based on historical facts, but rather on current expectations and on numerous assumptions regarding the business strategies and the environment in which the Company’s business shall operate in the future and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by those statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that may cause actual results to differ materially from our expectations as of the date of this report. These risks include, among other things, those set forth in Part I, Item 1A. Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2025, and otherwise in our reports and filings with the Securities and Exchange Commission ("SEC"), as well as the following factors:
•
Risks associated with the implementation of our strategic growth initiatives, including diversification, and the Company's understanding of, and entry into, new industries and technologies;
•
Risks associated with acquisitions, dispositions, strategic transactions and global asset realignment initiatives of Mativ;
•
Adverse changes in our end-market sectors impacting key customers;
•
Changes in the source and intensity of competition in our commercial end-markets;
•
Adverse changes in sales or production volumes, pricing and/or manufacturing costs;
•
Seasonal or cyclical market and industry fluctuations which may result in reduced net sales and operating profits during certain periods;
•
Risks associated with our technological advantages in our intellectual property and the likelihood that our current technological advantages are unable to continue indefinitely;
•
Supply chain disruptions, including the failure of one or more material suppliers, including energy, resin, fiber, and chemical suppliers, to supply materials as needed to maintain our product plans and cost structure;
•
Increases in operating costs due to inflation and continuing increases in the inflation rate or otherwise, such as labor expense, compensation and benefits costs;
•
Our ability to attract and retain key personnel, labor shortages, labor strikes, stoppages or other disruptions;
•
Changes in general economic, financial and credit conditions in the U.S., Europe, China and elsewhere, including the impact thereof on currency exchange rates (including any weakening of the Euro) and on interest rates;
•
A failure in our risk management and/or currency or interest rate swaps and hedging programs, including the failures of any insurance company or counterparty;
33
•
Changes in the manner in which we finance our debt and future capital needs, including potential acquisitions;
•
Changes in tax rates, the adoption of new U.S. or international tax legislation or exposure to additional tax liabilities;
•
Uncertainty as to the long-term value of the common stock of Mativ;
•
Changes in employment, wage and hour laws and regulations in the U.S. and elsewhere, including unionization rules and regulations by the National Labor Relations Board, equal pay initiatives, additional anti-discrimination rules or tests and different interpretations of exemptions from overtime laws;
•
The impact of tariffs, the imposition of any future additional tariffs and other trade barriers, the effects of retaliatory trade measures, and the impact of tariff uncertainty on macroeconomic conditions;
•
Existing and future governmental regulation and the enforcement thereof that may materially restrict or adversely affect how we conduct business and our financial results;
•
Weather conditions, including potential impacts, if any, from climate change, known and unknown, and natural disasters or unusual weather events;
•
Risks associated with international conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, and conflicts in the Middle East, and their corresponding impact on global macroeconomic conditions (including volatility in oil prices), as well as adverse impacts on our ability to supply products into affected regions, due to the corresponding effects on demand, the application of international sanctions, or practical consequences on transportation, banking transactions, and other commercial activities in troubled regions;
•
Compliance with the FCPA and other anti-corruption laws or trade control laws, as well as other laws governing our operations;
•
Risks associated with pandemics and other public health emergencies;
•
The number, type, outcomes (by judgment or settlement) and costs of legal, tax, regulatory or administrative proceedings, litigation and/or amnesty programs;
•
Increased scrutiny from stakeholders related to environmental, social and governance ("ESG") matters, as well as our ability to achieve our broader ESG goals and objectives;
•
Costs and timing of implementation of any upgrades or changes to our information technology systems;
•
Failure by us to comply with any privacy or data security laws or to protect against theft of customer, employee and corporate sensitive information;
•
Information technology system failures, data security breaches, network disruptions, and cybersecurity events; and
•
Other factors described elsewhere in this document and from time to time in documents that we file with the SEC.
All forward-looking statements made in this document are qualified by these cautionary statements. Forward-looking statements herein are made only as of the date of this document, and Mativ undertakes no obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise, or changes in future operating results over time or otherwise. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance unless expressed as such and should only be viewed as historical data.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Our market risk exposure at September 30, 2026 is consistent with, and not materially different than, the market risk and discussion of exposure presented under the caption "Quantitative and Qualitative Disclosures about Market Risk" in Part II, Item 7A of our Annual Report on Form 10-K for the year ended December 31, 2025.
34
Item 4.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
We currently have in place systems relating to disclosure controls and procedures designed to ensure the timely recording, processing, summarizing and reporting of information required to be disclosed in periodic reports under the Securities Exchange Act of 1934, as amended. These disclosure controls and procedures include those designed to ensure that such information is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions about required disclosure. Upon completing our review and evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2026, our Chief Executive Officer and Chief Financial Officer have concluded that these controls and procedures were effective as of September 30, 2026.
Changes in Internal Control Over Financial Reporting
No changes in our internal control over financial reporting were identified as having occurred in the fiscal quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
35
PART II - OTHER INFORMATION
Item 1.
Legal Proceedings
The Company is subject to various claims and pending or threatened lawsuits in the normal course of business. The Company is not currently a party to any legal proceedings that it believes would have a material adverse effect on its financial position, results of operations, or cash flows. Refer to Note 10. Commitments and Contingencies of the notes to the unaudited condensed consolidated financial statements included in this report.
Item 1A.
Risk Factors
There have been no material changes to the risk factors described in our Annual Report on Form 10-K for the year ended December 31, 2025. In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the factors discussed in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
Purchases of Equity Securities By the Issuer and Affiliated Purchasers
In August 2023, the Board of Directors authorized the repurchase of shares of Mativ Common Stock in an amount not to exceed $30.0 million. Under the current $30.0 million authorization, the Company repurchased 539,386 shares for $8.0 million cumulatively as of November 2, 2026.
The Company did not repurchase shares during the three months ended September 30, 2026, and the remaining amount of share repurchases currently authorized by our Board of Directors as of September 30, 2026 is $22.0 million.
Item 3.
Defaults Upon Senior Securities
Not applicable.
Item 4.
Mine Safety Disclosures
Not applicable.
Item 5.
Other Information
Securities Trading Plans of Directors and Executive Officers
During the fiscal quarter ended September 30, 2026, none of the Company’s directors or executive officers
adopted
or
terminated
any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement."
36
Item 6.
Exhibits
Exhibit
Number
Exhibit
3.1
Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2009).
3.2
Certificate of Amendment to the Certificate of Incorporation of the Company (filed on August 21, 1995), effective as of July 6, 2022 (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on July 6, 2022).
3.3
Amended and Restated Bylaws (incorporated by reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed on March 11, 2025).
*31.1
Certification of the Chief Executive Officer pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, as amended.
*31.2
Certification of the Chief Financial Officer pursuant to Rule 13a-14(a)/15(d)-14(a) of the Securities Exchange Act of 1934, as amended.
*32
Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101
The following materials from the Company's Quarterly Report on Form 10-Q for the quarter ended September 30, 2026, formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the unaudited condensed consolidated statements of income (loss), (ii) the unaudited condensed consolidated statements of comprehensive income (loss), (iii) the unaudited condensed consolidated balance sheets, (iv) the unaudited condensed consolidated statements of changes in stockholders' equity, (v) the unaudited condensed consolidated statements of cash flows, and (vi) notes to unaudited condensed consolidated financial statements.
104
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
* Filed herewith
+ Indicates management compensatory plan or arrangement
37
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Mativ Holdings, Inc.
(Registrant)
By:
/s/ Shruti Singhal
Shruti Singhal
President and Chief Executive Officer
(duly authorized officer and principal executive officer)
November 5, 2026
By:
/s/ Scott Minder
Scott Minder
Executive Vice President and
Chief Financial Officer
(duly authorized officer and principal financial officer)
November 5, 2026
38